“I-MOVE” towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9
Esther Kissling, Alain Moren(Health Service Executive), Marta Valenciano(World Health Organization), Daniela Pițigoi(Carol Davila University of Medicine and Pharmacy), Camelia Savulescu(Instituto de Salud Carlos III), Beatrix Oroszi, Amparo Larrauri(Instituto de Salud Carlos III), José Marinho Falcão(National Institute of Health Dr. Ricardo Jorge), Baltazar Nunes(University of Lisbon), B C Ciancio(European Centre for Disease Prevention and Control), A Mazick(Statens Serum Institut), Emilia Lupulescu(Institutul Cantacuzino), Katarina Widgren(Statens Serum Institut)
Cited by 82
Related Papers
Ambient Particulate Air Pollution and Daily Mortality in 652 Cities
|New England Journal of Medicine|2019|1.7k
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303